CD8A and neoplasm: CD8+ cytotoxic T-lymphocytes can eradicate cancer cells, leading to higher response to therapies and better prognosis, but often these cells become exhausted, exhibiting reduced proliferation and decreased production of IFN-γ, and are unable to kill tumor cells [76].